OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Minimising the environmental impact of inhaled therapies: problems with policy on low carbon inhalers
Duncan Keeley, Jane Scullion, Omar S. Usmani
European Respiratory Journal (2020) Vol. 55, Iss. 2, pp. 2000048-2000048
Open Access | Times Cited: 18

Showing 18 citing articles:

The environmental impact of inhalers: a framework for sustainable prescription practices in Spain
Noé Garín, Borja Zarate-Tamames, Unax Lertxundi, et al.
European Journal of Hospital Pharmacy (2025), pp. ejhpharm-004402
Closed Access

<p>The Climate is Changing for Metered-Dose Inhalers and Action is Needed</p>
J.N. Pritchard
Drug Design Development and Therapy (2020) Vol. Volume 14, pp. 3043-3055
Open Access | Times Cited: 63

The carbon footprint of as-needed budesonide/formoterol in mild asthma: apost hocanalysis
Lee Hatter, Mark Holliday, Allie Eathorne, et al.
European Respiratory Journal (2024) Vol. 64, Iss. 1, pp. 2301705-2301705
Closed Access | Times Cited: 4

Reducing carbon footprint of inhalers: analysis of climate and clinical implications of different scenarios in five European countries
Daniele Pernigotti, Carol Stonham, Sara Panigone, et al.
BMJ Open Respiratory Research (2021) Vol. 8, Iss. 1, pp. e001071-e001071
Open Access | Times Cited: 33

Canadian Thoracic Society Position Statement on Climate Change and Choice of Inhalers for Patients with Respiratory Disease
Samir Gupta, Simon Couillard, Geneviève C. Digby, et al.
Canadian Journal of Respiratory Critical Care and Sleep Medicine (2023) Vol. 7, Iss. 5, pp. 232-239
Open Access | Times Cited: 10

Patient and Provider Perspectives Driving Inhaler Choice
Graham Lough, Sinthia Bosnic‐Anticevich, Nicolás Roche, et al.
CHEST Journal (2024) Vol. 166, Iss. 5, pp. 934-937
Open Access | Times Cited: 2

Effective respiratory management of asthma and COPD and the environmental impacts of inhalers
Omar S. Usmani, Mark L Levy
npj Primary Care Respiratory Medicine (2023) Vol. 33, Iss. 1
Open Access | Times Cited: 7

Impact of Inhalers Used in the Treatment of Respiratory Diseases on Global Warming
Andrzej Emeryk, Tomasz R. Sosnowski, Maciej Kupczyk, et al.
Advances in respiratory medicine (2021) Vol. 89, Iss. 4, pp. 427-438
Open Access | Times Cited: 17

Reduktion klimaschädlicher Treibhausgase durch Auswahl der Inhalatoren in der Therapie von Patienten mit Asthma und COPD
J Bickhardt, Cornelia Czupalla, Uta Bader
Pneumologie (2022) Vol. 76, Iss. 05, pp. 321-329
Open Access | Times Cited: 7

Health-care Resource Requirements and Potential Financial Consequences of an Environmentally Driven Switch in Respiratory Inhaler Use in England
Darsuh Attar-Zadeh, Harriet Lewis, Martina Orlović
Journal of health economics and outcomes research (2021) Vol. 8, Iss. 2
Open Access | Times Cited: 7

Health-care Resource Requirements and Potential Financial Consequences of an Environmentally Driven Switch in Respiratory Inhaler Use in England
Darsuh Attar-Zadeh, Harriet Lewis, Martina Orlović
Journal of health economics and outcomes research (2021) Vol. 8, Iss. 2, pp. 46-54
Open Access | Times Cited: 7

Recomendações para a Redução do Impacto Ambiental dos Inaladores em Portugal: Documento de Consenso
L. M. A. Campos, Paula Rosa, Pedro Carreiro Martins, et al.
Acta Médica Portuguesa (2024) Vol. 37, Iss. 9, pp. 654-661
Open Access

Pharmaceutical Therapies for Pediatric Respiratory Disease: Setbacks and Progress in 2024
Scott Bickel, Ronald Morton
Pediatric Allergy Immunology and Pulmonology (2024) Vol. 37, Iss. 3, pp. 64-67
Closed Access

Aerosolized drug delivery in awake and anesthetized children to treat bronchospasm
Natalie Anderson, Sarah Clarke, Britta S. von Ungern‐Sternberg
Pediatric Anesthesia (2021) Vol. 32, Iss. 2, pp. 156-166
Closed Access | Times Cited: 5

Réduire l’impact environnemental des inhalateurs dispensés en ville et à l’hôpital en France. Du diagnostic à l’action durable
J. Leraut, L. Boissinot, Y. Hassani, et al.
Annales Pharmaceutiques Françaises (2022) Vol. 81, Iss. 1, pp. 123-137
Closed Access | Times Cited: 2

Minimising the environmental impact of inhaled therapies
Lauri Lehtimäki, Unnur Steina Björnsdóttir, Christer Janson, et al.
European Respiratory Journal (2020) Vol. 55, Iss. 5, pp. 2000721-2000721
Open Access | Times Cited: 1

Is the path to greener inhalers paved with good intentions?
David Erskine
Drug and Therapeutics Bulletin (2022) Vol. 60, Iss. 3, pp. 34-34
Closed Access

Page 1

Scroll to top